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ABSTRACT
Deciphering the etiology of complex pathologies
at molecular level requires longitudinal studies en-
compassing multiple biochemical pathways (apop-
tosis, proliferation, inflammation, oxidative stress).
In vivo imaging of current reporter animals enabled
the spatio-temporal analysis of specific molecular
events, however, the lack of a multiplicity of loci for
the generalized and regulated expression of the inte-
grated transgenes hampers the creation of systems
for the simultaneous analysis of more than a bio-
chemical pathways at the time. We here developed
and tested an in vivo-based methodology for the
identification of multiple insertional loci suitable for
the generation of reliable reporter mice. The validity
of the methodology was tested with the generation
of novel mice useful to report on inflammation and
oxidative stress.
INTRODUCTION
The next frontier of biological research resides in the cre-
ation of reliable tools to investigate the dynamics of in-
teraction among multiple biochemical pathways in living
organisms. This is now possible by the combined applica-
tion of genetic engineering with the use of appropriate re-
porters (such as radiolabeled, bioluminescent or fluores-
cent molecules) facilitating the in vivo imaging of molecular
events.
Prototypes of ‘reporter animals’ (i.e. organisms engi-
neered to carry an easily measurable, surrogate molecule
able to portray specific biological events) have demon-
strated their significant investigational powerfulness (1), yet
more work is required to lead to the generation of more per-
formant models where the ubiquitous expression of multi-
ple reporters may give the visual representation in real time
of the changes and interactions of several biochemical path-
ways in response to physiological, pathological or environ-
mental stimuli at systemic level. The knock-in integration
of a reporter gene downstream of the selected promoter (2–
5) has been the methodology of choice to measure spatio-
temporally the expression of the genes of interest; however,
with this method the disruption of the gene in study of-
ten perturbs cellmetabolismwith phenotypic consequences,
particularly when the animal is homozygous. More impor-
tantly, the knowledge of the dynamics of expression of a
single gene seldom gives the necessary insights into biolog-
ical processes relevant for patho-physiological studies (i.e.
inflammation, oxidative stress, cell death). This latter exper-
imental need has been successfully addressed with the cre-
ation of ‘path activity reporters’ characterized by the use
of a reporter transcriptionally regulated by the transducers
of relevant biological processes such as nuclear receptors,
NFY, Nrf2 and others (6–12). Ideally, we could generate
‘path activity reporters’ for the investigation of the activ-
ity of multiple molecular events at the same time facilitat-
ing tremendously physio-pathological studies. For instance,
cancer and cancer drugs could be studied in animals where
proliferation and apoptosis could be measured at the same
time and in different tissues or the understanding of molec-
ular basis of neurodegenerative disorders would advance
significantly by analyzing oxidative stress and apoptosis (6).
Unfortunately, the key element to obtain this ‘path activity
reporters’ requires the availability of genomic lociwhere the
expression of the integrated reporter is ubiquitous and in-
ducible in all the cells of the organism of interest.
This aspect has significantly hampered the expansion
of this field because the number of mammalian loci en-
abling the constitutive and regulated expression of exoge-
nous transgenes is still very limited. At present time the loci
most extensively exploited for the generalized expression of
a transgene are the hrpt and rosa26 (13,14); both shown
to suffer of shortcomings. The hrpt gene, located on the X
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chromosome is subject to random X-inactivation, thus, the
expression of the integrated gene is guaranteed only in ho-
mozygous females; in addition, in mouse tissues like kidney
and liver the activity of promoters in this locus is low or un-
detectable (14,15). So far, the rosa26 (Gt(ROSA)26Sor) is
considered as the best available site for the ubiquitous ex-
pression of transgenes, but the generation of ‘path activity
reporters’ demands the availability of a multiplicity of reli-
able sites for the ubiquitous and regulated expression of the
transgenes.
To overcome current shortage of bona fide permissive
loci, we applied a systematic approach aimed at finding and
testing novel integration sites for the ubiquitous and reg-
ulated expression of exogenous, homologous and heterolo-
gous genes. Taking advantage of in vivo imaging, we here de-
scribe a novel work process that facilitates the identification
of suitable loci. In addition, we demonstrate the efficacy of
such methodology with the full characterization of two of
the numerous integration sites identified and the generation
of two novel reporter mice.
MATERIALS AND METHODS
Reagents
Primers were synthetized by Primm srl (Milan, Italy).
Cells culture and transient transfections
All cell lines were purchased from the American Type
Culture Collection (Manassas, VA, USA) and grown in
media containing streptomycin–penicillin (50 000 U plus
50 mg/l) in a humidified 5% CO2-95% air atmosphere
at 37◦C. RAW264.7 cells were grown in red-phenol free
Dulbecco’s minimal essential medium (DMEM)-10%DCC
serum (DCC) (EuroClone,Milan, Italy) supplemented with
2 g of sodium carbonate per liter, 0.11 g of sodium pyruvate
per liter; MCF-7 cells were grown in ATCC-formulated Ea-
gle’s Minimum Essential Medium with 0.01 mg/ml bovine
insulin (Euroclone, Milan, Italy), fetal bovine serum to a fi-
nal concentration of 10% (EuroClone, Milan, Italy); NIH-
3T3 cells were grown in ATCC-formulated DMEM plus
bovine calf serum to a final concentration of 10% (Euro-
Clone, Milan, Italy).
For the transfection, RAW264.7 and MCF-7 cells were
seeded in a 24-well plates (100.000 cells/well) and cultured
overnight prior transfection. For NIH-3T3 cells, we seeded
25.000 cells/well. All transfections were carried out using
FUGENE HD (Roche, Milan, Italy), following the manu-
facturer’s instructions using a DNA: FUGENE HD ratio
of 2:6.
Animal treatments
All animal experimentation was carried out in accordance
with the ARRIVE and European Guidelines for Animal
Care. All animal experiments were approved by the Italian
Ministry of Research and University and controlled by a
Departmental panel of experts.
The animals were fed ad libitum and housed in individ-
ually ventilated plastic cages within a temperature range of
22–25◦C, relative humidity of 50% ± 10% and under an au-
tomatic cycle of 12 h light/dark (lights on at 07:00 am).
For the lipopolysaccharide (LPS) study, NFB-luc2mice
were injected i.p. at indicated time and doses with LPS (LPS
from Escherichia Coli L4130 Sigma Aldrich, St. Louis, MO
63103, USA) or vehicle (PBS). For the NaArsenite (ASN)
study the dose administered i.p. to the ARE-luc2 mice, was
12.5 mg/kg of ASN (Sodium (meta) arsenite S7400 Sigma
Aldrich, St. Louis, MO 63103, USA) or vehicle (PBS).
Design and identification of a promoter for ubiquitous expres-
sion of luciferase
The promoter sequence of UBC-luc2, mUBC-luc2,
Enhanced-Cytomegalovirus-UBC-luc2 (ECMV-UBC-luc2)
plasmids was cloned, using standard cloning procedures,
in pGL4.10 vector (Promega Corp., Madison, WI, USA):
i) A total of 1219-bp DNA fragment encoding UBC
was amplified with Phusion Enzyme (Phusion®High-
Fidelity DNA Polymerase, Euroclone, Milan, Italy)
from genomicDNA extracted fromMCF-7 cell line, us-
ing this primers:
-1225-f- EcoRV 5′- gatatctatccacccgctcccggtgcagc-3′
-6-r-HindIII 5′- aagctttggtggcaacaaaaaagccaaaaac -3′
and cloned into the EcoRV/HindIII restriction sites.
ii) Minimal UBC was amplified from UBC-luc2 plasmid
with Phusion Enzyme using this primers:
-844-f-EcoRV 5′- gatatctttgtggatcgctgtgatcgtcac -3′
-6-r-HindIII 5′ - aagctttggtggcaacaaaaaagccaaaaac -3′
and cloned into the EcoRV/HindIII restriction sites.
iii) ECMVwas amplified from pGL4.50 plasmid (Promega
Corporation Madison, WI, USA), with Phusion En-
zyme using this primers:
225-f-XhoI 5′- ctcgagcgcgttacataacttacgg -3′
632-r-EcoRV 5′- gatatcccaaaacaaactcccattgac -3′
and cloned in UBC-luc2 in XhoI/EcoRV restriction
sites.
The plasmid for the initial blastocyst injections (random
integration), mUBC-luc2 plasmid was cloned in XhoI/SalI
restriction sites in pgk-HPRT plasmid (kindly provided by
PolyGene AG, CH).
NFB-loxP-STOP1x-loxP-luc2-ires-TdTomato design and
generation
In the NFB-loxP-STOP1x-loxP-luc2-ires-TdTomato vec-
tor each functional cassette was flanked with unique restric-
tion sites to facilitate further manipulations. Each element
was sequentially cloned in the pGL4.10 vector (Promega
Corp., Madison, WI, USA) using standard cloning proce-
dures.
i) the NFB responsive promoter was obtain as previ-
ously described (16) first by cloning into AseI/SalI re-
striction sites of pBluescript II KS+ (Strategene, Ag-
ilent Tecnologies, Santa Clara, USA) four NFB re-
sponsive elements identified by bioinformatic analysis
and named 2A, 2B, 1A and 1B. Each element was syn-
thetized by Eurofins Genomics, Ebersberg Germany as
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a dimer. Then the 220-bp DNA fragment of NFB re-
sponsive elements andTATAminimal promoterwas ex-
cised and cloned into the EcoRV/SnaBI restriction sites
in the pGl2 basic vector (Promega Corp.,Madison,WI,
USA).
ii) the 3185-bp loxP-STOP1x-loxP fragment was excised
from LSL-TOPO plasmid (Addgene, USA cat number
11584) and cloned in the SalI restriction site. To ob-
tain STOP1Xwe performed a partial digestion with the
MfeI restriction enzyme.
iii) the 641-bp DNA fragment encoding internal ribosome
entry site (IRES) element was excised from pIRES vec-
tor (Clontech Laboratories, Inc., 1290 Terra Bella Ave.
Mountain View, CA 94043, USA) and cloned into the
XbaI/FseII sites.
iv) the 1430-bp TdTomato sequence was excided from
pRSET-B tdTomato plasmid (kindly provided by Prof.
R.Tsien’s lab), and cloned into the XhoI/EcoRV site.
Once obtained, the NFB-loxP-STOP1x-loxP-luc2-ires-
TdTomato plasmid was cloned in BstBI/XhoI site in the
pTargeting-19 plasmid.
In the pTargeting-19 each element was sequentially
cloned, using standard cloning procedures, in the pFlrt vec-
tor (kindly provided by CFCM- San Raffaele – DIBIT-Mi-
lan, Italy):
i) the 3′ homology region (line 19) was amplified from ge-
nomic DNA isolated from embryonic stem (ES) cells
v6.4 using these primers:
3HR 2231 xma f 5′-cagcccgggtctctctctttctttctttcttttcca
gag-3′
3HR 4230 not-sal r 5′-aatgtcgacgcggccgcagccacagaga
gtatgtggggaaga-3′
and cloned in SalI/XmaI restriction sites;
ii) a single copy of MAR (3-kb DNA fragment) from
chicken lysozyme gene was excised with digestion of the
pBSKMAR, kindly provided by L.Hennighausen (17)
and cloned in the NheI/ClaI in place of neomycin cas-
sette in pFlrt vector;
iii) a second copy of MAR was cloned in the KpnI/XhoI
site;
iv) the 5′ homology region (line 19) was amplified from
genomic DNA isolated from ES cells v6.4 using these
primers:
5HR-f AatII Not 5′-atgacgtcgcggccgccagggttaaagccc
agtaagatggaggcca-3′
5HR-r Mlu 5′-atacgcgtgaaggaaggaaggggaaaggcctaca
gctcag-3′
and cloned in AatII/MluI restriction sites.
ARE-loxP-STOP1x-loxP-luc2-ires-TdTomato design and
generation
The ARE-loxP-STOP1x-loxP-luc2-ires-TdTomato vector
was cloned simply by substituting the promoter sequence
of the NFB-loxP-STOP1x-loxP-luc2-ires-TdTomato vec-
tor with antioxidant responsive element (ARE) promoter
sequence.
ARE was obtain by cloning four selected Nrf-2 respon-
sive elements repeated twice into the XhoI/XmaI site of
pBluescript II KS+ (Strategene, Agilent Tecnologies, Santa
Clara, USA). These responsive elements had been identified
by bioinformatic analysis and synthetized by Eurofins Ge-
nomics, Ebersberg, Germany. Then the 325-bp DNA frag-
ment of ARE responsive element and the TK minimal pro-
moter were excised and cloned into the XhoI/XmaI of the
NFB-loxP-STOP1x-loxP-luc2-ires-TdTomato vector.
ES manipulation: random integration of the mUBC-luc2-
pgk-HPRT
The plasmid mUBC-luc2-pgk-HPRT was linearized with
NotI, the transgene was separated from plasmid sequences
and electroporated into embryonic stem cells 129Ola. The
ES cells were grown on murine embryonic fibroblasts in
DMEM-N supplemented with 15% fetal bovine serum, 0.1
mM 2-mercaptoethanol and 2 mM L-glutamine. Trans-
fected cells were selected in the hypoxanthine-aminopterin-
thymidine (HAT) medium (0.016 mg of hypoxanthine per
ml/0.0.1 mM aminopterin/0.0048 mg of thymidine per ml)
for around 10 days, at which time individual colonies were
picked for expansion. A total of 86 clones were obtained
and pooled (3 pools of 10 clones each and 7 pools of 8 clones
each). Each pools was injected in C57Bl/6 blastocysts and
then implanted in the oviducts of in vitro culture-held foster
mice. The resulting chimeric mice were crossed to C57BL/6
to generate the F1.
ES manipulation: homologous recombination of NFB and
ARE plasmids
The targeting vector ARE/NFB-targeting-19 was lin-
earized with NotI and transferred into sv6.4 embryonic
stem cells by electroporation: 35 g/DNA each using 15
million cells (Core Facility for Conditional Mutagenesis,
DIBIT San Raffaele, Milan, Italy). Positive clones were se-
lected with puromycin (1 g/l). More than four hundred
resistant clones for each transgene were screened for homol-
ogous recombination by PCR.One out of six positive clones
in the case of NFB and one out of eight positive clones
in the case of ARE, were injected into C57BL/6NCrL
blastocyts which are transferred to pseudo-pregnant CD-
1 females. We obtained two chimeric male mice (with 80–
90% of chimerism) that were mated to wild-type (WT)
C57BL/6NCrL female mice to produce F1 transgenic mice.
In vivo and ex vivo imaging
In vivo imaging: for the semi-quantitative analysis of pho-
ton emission, animals were injected i.p. with 80 mg/kg
of luciferin (Beetle Luciferin Potassium Salt; Promega,
Madison, WI, USA) 15 min prior the imaging session.
For the imaging, mice were anaesthetized using Isofluo-
rane (Isofluorane-Vet; Merial, Lyon, France) and kept un-
der anesthesia during the 5 min of the session carried out
with a CCD-camera (IVIS Lumina II Quantitative Fluores-
cent and Bioluminescent Imaging; PerkinElmer, Waltham,
MA, USA). Photon emission in selected body areas was
measured, respectively, using the Living Image Software
(PerkinElmer).
Ex vivo imaging: the selected organs were dissected from
mice treated with luciferine 15 min prior euthanasia and
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subjected to ex vivo imaging immediately after death. Imag-
ing analysis was done by 5 min exposures of the tissue ex-
plants. Photon emission was quantified with the Living Im-
age Software (PerkinElmer).
Luciferase enzymatic assay
Organs were homogenized in lysis buffer and lysates were
subjected to three cycles of freezing and thawing. Proteins
were separated fromDNA and lysosomes by centrifugation
(13000 × g for 30min), after having measured the protein
concentration of the extract by the Bradford assays (18),
the biochemical assay of Luciferase activity was carried out
with a luciferase assay buffer (470 m luciferine, 20 mm
Tricine, 0.1 mm EDTA, 1.07 mm (MgCO3)4·Mg(OH)2 ×
5H2O; 2.67 mm MgSO4 × 7H2O in H2O, pH 7.8, with
33.3 mm DTT and 530 m ATP) by measuring lumines-
cence emission with a luminometer. The relative lumines-
cence units (RLU) determined during a measurement of 10
s time was expressed as RLU per microgram protein. RLU
were measured in all organs of WT mice; the average RLU
measuredwas 35. TheRLUmeasured inWTmice were rou-
tinely subtracted from the RLU measured in the TG mice.
Site finder PCR
Mouse genomic DNA was extracted from the mice tails (19
and 21 mouse lines) in accordance with the manufacture in-
struction (EUROGOLD Tissue-DNA Mini Kit form Eu-
roclone, Milan, Italy). The steps of site finder PCR were
slightly modified from Tan et al. 2005 (19) as follows:
i) SiteFinder annealing: after low temperature priming by
a Site Finder, one strand of the target gene was re-
placed by Phusion Enzyme (Phusion® High-Fidelity
DNA Polymerase, Euroclone, Milan, Italy) that gen-
erated double-stranded target molecules of different
lengths;
ii) exponential amplification and nested PCR: the target
DNA was exponentially amplified by nested PCR with
gene specific primers 1, 2 and 3 (GSP) and SiteFinder
primers 1 and 2 (SFP);
iii) cloning target sequence: the PCR products (gener-
ated by SFP2-GSP3 and SFP2-GSP2) were loaded on
agarose gel, the bands with expected molecular weight
were excised, purified and cloned in the pCRII-TA vec-
tor (Thermo Fisher Scientific, Waltham, MA 02451,
USA);
iv) screening and sequencing: the clones were screened by
colony-PCR with GSP3 and SPF2 and the positive
clones were sequenced (Primm srl, Milan, Italy).
Site finder 5′- cacgacacgctactcaacacaccacctcgcacagcgtcct
caagcggccgcNNNNNNgcct-3′
SPF1 5′- cacgacacgctactcaacac-3′
SPF2 5′- actcaacacaccacctcgcacagc-3′
GSP1 5′- cgagcagacatgataagatacatt -3′
GSP2 5′- ggacaaaccacaactagaatgcagtg -3′
GSP3 5′- tcattttatgtttcaggttcagggg -3′
Immunohistochemical analysis
ARE-luc2 mice were sacrificed and perfused transcardially
with cold saline solution followed by 4% paraformaldehyde
in PBS. Brains were immediately removed, post-fixed in the
4% paraformaldehyde fixative for 24 h and then transferred
in solutions of sucrose at increasing concentrations (up to
30%) during the following 72 h. Samples were then frozen
and stored at −80◦C for successive analyses. Serial coronal
sections of 40 m were cut throughout the brain using a
freezing sliding microtome (Leika SM 2000R) and stored
at−20◦C in a solution containing 30% ethylene glycol, 20%
glycerol and 0.05M sodium phosphate buffer until use. The
slide-mounted sections were rinsed in PBS and incubated in
PBS containing 10% NGS and 0.3% TX-100 at room tem-
perature. Sections were then incubated at 4◦C in PBS/1%
NGS/0.3% TX-100 containing a rabbit polyclonal anti-
RFP antibody (diluted 1:400; Abcam, Cambridge, UK).
After a 24 h incubation sections were rinsed in PBS and in-
cubated 1 h at RT in PBS/1% NGS containing the Alexa
Fluor 594 conjugated goat anti-rabbit IgG antibody (1:300;
Molecular Probes, Carlsbad, CA, USA). Finally, sections
were rinsed in PBS and covered with Prolong with DAPI
(Molecular Probes, Carlsbad, CA, USA).
Real-time PCR
Total RNAs were extracted after tissue homogenization in
TRIzol reagent (Invitrogen, Carlsbad, CA) as suggested
by the manufacturer’s instructions. For the preparation of
cDNA, 1 g of RNA was denatured at 75◦C for 5 min in
the presence of 1.5 g of random primers (Promega) in a 15
l final volume.Deoxynucleotide triphosphate (GEHealth-
care) andMoloneymurine leukemia virus reverse transcrip-
tase (RT; Promega) were added at 0.5 mM and 8 U/l final
concentration, respectively, in a final volume of 25 l. The
RT reaction was carried out at 37◦C for 1 h; the enzyme
was inactivated at 75◦C for 5 min. For each sample control
reactions were done routinely omitting the addition of the
reverse transcriptase. A 1:4 cDNA dilution was amplified
using SYBR green chemistry. The qPCR was carried out in
triplicate on a 96-well plate using GoTaq®qPCR Master
Mix technology (Promega) according to the manufacturer’s
protocol with a 7900HT fast real time PCR system (Applied
Biosystems, Life Technologies) with the following thermal
profile: 2 min at 95◦C; 40 cycles, 15 s at 95◦C, 1 min at 60◦C.
The following primers were used:
36B4: forward 5′-ggcgacctggaagtccaact-3′, reverse 5′-ccat
cagcaccacagccttc-3′;
Enah: forward 5′-gctaaggccccatcaacaag-3′, reverse 5′-ag
gtgtggatttgggtctgg-3′;
Srp9: forward 5′-acgatgcctcagttccagac-3′, reverse 5′-gtct
tgcgcttggtctgttc-3′;
Sephs2: forward 5′-gacagcccggatcattgaca-3′, reverse 5′-cg
agttcccaacaaccgcta-3′;
Itga1: forward 5′-cgtgtcatctccttccctcg-3′, reverse 5′-atag
ccagctctcgtttccg-3′;
Il6: forward 5′- ctggatataatcaggaaatttgcct-3′, reverse 5′ -
tggggtaggaaggactattttatgt-3′;
Il1: forward 5′- tgccaccttttgacagtgatg -3′, reverse 5′- gc
tgcgagatttgaagctgg -3′;
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Cxcl2: forward 5′-tgaacaaaggcaaggctaactgacc-3′, reverse
5′- acgatccaggcttcccgggtg-3′;
Nrf2: forward 5′-cccagcaggacatggatttg-3′, reverse 5′- agct
catagtccttctgtcgc-3;
The data were analyzed using the ABI Prism 7000 SDS
Software and the 2−Ct method or Ct using 36b4 as the
housekeeping gene.
Statistical analysis
Was done byANOVA followed by Bonferroni’s test formul-
tiple comparisons (Graph Pad 5 software).
RESULTS
The strategy we pursued was based a series of sequential
steps aimed at identifying loci permissible for expression in
all tissues; the second had the goal to systemically test the
suitability of the loci identified for the regulated and gen-
eralized expression of a reporter driven by a minimal, in-
ducible promoter. To pursue such an experimental design,
we identified three steps: (i) electroporation of ES cells with
a construct expressing constitutively a non-mammalian re-
porter protein of easy detection under the control of a
strong, ubiquitous promoter; (ii) bioluminescence (BLI)-
based imaging for the insertional screening in cells and then
in animal lines to select the mice where the integrated gene
was expressed spatio-temporally at relatively high level and
with the least possible variability; (iii) identification of the
new loci and testing of their efficacy by the integration of
specific reporter genes flanked by insulators sequences to
best shield the exogenous transgene from position effects
and to ensure that the reporter can be fully regulated by the
given transcription factor.
Electroporation of ES cells with a construct expressing con-
stitutively a non-mammalian reporter
To secure the highest probability to identify the positive ES
clones and animal lines we needed a reporter suitable for
in vivo imaging driven by a promoter ensuring the consti-
tutive, unrestricted, high expression of the reporter. For the
reporter, we selected the luc2 (20), a firefly luciferase engi-
neered to generate a luminescence 4- to 5-fold greater than
the native enzyme. This reporter was considered most ap-
propriate for an efficient identification of the positive ES
clones after electroporation, but, more importantly, for the
rapid quantitative and qualitative analysis of the reporter
expression in living animals. To design the promoter first we
took into consideration the cytomegalovirus (CMV) pro-
moter generally considered of choice and we generated a
construct containing the CMV (Human cytomegalovirus
immediate early promoter derived from pGL4.50 plasmid
from Promega Corporation cod E1310) (Figure 1A, 1);
however, based on our initial experience corroborated by
data in the literature we did not feel that this promoter
would have guaranteed the ubiquitous expression of the
reporter (21–24), therefore, we contemplated the use of a
mammalian ubiquitous promoter and, based on an exten-
sive literature search, we selected the human ubiquitin C
gene (NG 027722.2, Gene ID: 7316). We generated three
constructs, the first containing the sequence -1225 to -6 of
the human UBC promoter as indicated by Schaefer et al.
(25) for the generation of mice with widespread expression
of the reporter together with the CMV enhancer (from 225
to 632 bp of CMV derived from pGL4.50 plasmid from
Promega Corporation cod E1310) (Figure 1A, 2); the sec-
ond the UBC promoter alone (Figure 1A, 3) and the third
(Figure 1A, 4), a UBC promoter shorter version (minimal
UBC,mUBC) where most binding sites for regulatory tran-
scription factors were maintained as indicated by an un-
biased sequential informatics search (Transfect®6.0; Al-
iBaba 2.1 and Patch 1.0) (Figure 1B). These constructs were
transfected in parallel in three different cell lines: NIH-3T3;
RAW264.7 and MCF-7 and their efficiency in the produc-
tion of luciferase was compared with the ERE-Luc reporter
shown to generate a bioluminescence signal sufficient for in
vivo imaging by prior studies (1). Figure 1C shows that the
extent of Luc2 synthesis was of the same order ofmagnitude
for all constructs tested; this led us to select the smallest of
them mUBC-luc2 because the efficiency of the electropora-
tion process is known to be inversely proportional to the
dimension of the transgene.
BLI-based imaging for the insertional screening in animal
lines
After electroporation, the 129Ola ES cells were selected
in the HAT medium; we obtained a total of 86 positive
clones. To reduce the number of injections into blastocysts
we pooled the positive clones (3 pools with 10 clones each
and 7 with 8 clones). Each pool was injected in a C57Bl/6
blastocyst to produce a founder that was bred into C57Bl/6.
Each of the F1 mice had the potential to originate multi-
ple transgenic mouse lines; therefore, we needed a robust
methodology to identify the mouse lines in which the trans-
gene was expressed ubiquitously, trans-generationally, at all
stages of life. This process would not have been possible
without the aid of in vivo imaging that allowed us to mea-
sure the expression of the reporter in space and time.
Based on the above assumption the criteria for the ‘inser-
tional screening’ we set up as follows: (i) widespread pres-
ence of BLI, (ii) intensity and stability of BLI during the
entire life span; (iii) reproducibility of BLI expression in the
progeny; (iv) sex-independence of BLI expression.
The number of animal lines that met the criteria for the
insertional screening stated above were 22 (Supplementary
Figure S1) and all these animal lines showed single inte-
gration of the transgene, as demonstrated by quantitative
analysis of luc2 DNA content by real time PCR (data not
shown) and as expected after ES cells electroporation (26).
In each of these lines the pattern of BLI expression was dif-
ferent: this was the predictable outcome of a random inte-
gration of the transgene.
Identification of the new, permissive integration loci
To ensure that the screening done had led to the identifica-
tion of permissive loci we continued the study on 2 of the
22 lines available: lines 19 and 21 where the luciferase was
found to have the same pattern of expression from birth to
maturity in male and females for at least three generations
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Figure 1. Identification of a eukaryotic promoter for the ubiquitous expression of the luciferase reporter. (A) Schematic representation of plasmid vector
tested: (1) CMV-luc2 (pGL4.50 plasmid from Promega Corporation cod E1310); (2) ECMV-UBC-luc2 in which ECMV derived from cytomegalovirus
(CMV) (position 225–632) plus the promoter of human Ubiquitin C (position –1225 to –6 with respect to the start site), (3) promoter of human Ubiquitin
C (position –1225 to –6 with respect to the start site), (4)mUBCminimal promoter of the human Ubiquitin C (position –835 to –6 with respect to the start
site). (B) DNA sequence of human Ubiquitin C promoter region, the minimal region of Ubiquitin C used to generate mUBC-luc2 vector is highlighted
and the binding sites for general transcription factors were indicated with following code: light grey CAC binding site; grey TATA binding site as defined
by Transfect 6.0; AliBaba 2.1 and Patch1.0. (C) Transient transfection of the constructs shown in (A) in three cell lines: NIH-3T3, RAW264.7 and MCF7,
plus the plasmid ERE-luc (lane 5) The transfections were standardized by co-transfecting the plasmid CMV--gal. Data are expressed as luciferase activity
(RLU/g of total proteins), bars show means ±SEM (n = 6). The experiment was repeated twice with superimposable results.
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Figure 2. In vivo analysis by bioluminescence (BLI) of luciferase expression inmales and females of lines 19 and 21: F1–F3 generations. Pseudocolor images
of each individual mouse were obtained 15 min after the injection of 80 mg/kg luciferin with 5 min exposition time for line 19 and 3 mg/kg luciferin with 1
s exposition time for line 21. (A and B) In vivo imaging of a single, representative mouse indicates the pattern of luciferase expression of F1 mice at different
post-natal days. The mice analysed in total were 6; (C and D) BLI of adult male (M) and female (F) F1, F2 and F3; (E and F) Quantification of photon
emission from indicated body areas or regions of interest (ROIs). Data are expressed as BLI bioluminescence (photon/cm2/s/ster), mean ± SEM (n = 6).
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(Figure 2). Next, lines 19 and 21 were bred to homozygos-
ity to ascertain that the mice carrying the transgene in both
alleles were viable, fertile, had normal size and not obvious
phenotypic alterations.
In the homozygous mice, the generalized expression of
the reporter was confirmed ex vivo in 24 organs isolated
from anesthetized mice injected i.p. with luciferin 15 min
prior of euthanasia. Figure 3A–E shows that in both lines,
19 and 21, all the organs tested expressed the integrated re-
porter. However, the extent of LUC2 expression varied sig-
nificantly. In line 19, the expression measured in thymus
and testis was about 15-fold higher than in liver, muscle,
spleen and lung. In line 21, the reporter expression was gen-
erally higher than in line 19 and the organs with the highest
expression (liver and muscle) showed a content of LUC2
about 100-fold higher than heart and brain where the ex-
pression was lowest (Figure 3C). What observed has to be
ascribed to position effects as the transgene was not flanked
by insulators (8). Indeed, in the absence of insulators even
the expression of reporters integrated in the locusRosa26 is
quite variable (27). In fact the integration in this locus of En-
hanced Green Fluorescent Protein (EGFP) reporter under
the control the chicken-actin promoter had an inter-organ
variability of about 35-fold in the 9 organs tested and the cy-
tomegalovirus promoter did not show unbiquitous EGFP
expression (27).
Next, we proceeded with the identification of the site of
integration in the two transgenic line using a methodology
previously described (28) and illustrated in Supplementary
Figure S2.
In both mouse lines the transgene integration had oc-
curred in noncoding, intergenic DNA regions with un-
known function. More in detail, line 19 integration mapped
in chromosome 1, 10 208 bp 5′ of the Enah gene (enable
homolog isoform 1) and 94 173 bp 3′ of the Srp9 (signal
recognition particle 9kDa protein) (Figure 3D). The inte-
gration site of line 21 was in chromosome 7, 5445 bp 5′ of
Sephs2 gene (seleno phosphate synthetase 2) and 16 886 bp
3′ of Itga1 (integrin alpha 11) (Figure 3E). To ensure that in
the two lines the transgene integration did not interfere with
the activity of the proximal genes we measured their expres-
sion in WT and transgenic lines. Supplementary Figure S3
shows that the integration did not significantly affected the
expression of the 4 genes 5′ and 3′ of the integration site:
Enah, Srp9, Sephs2 and Itga1.
Generation of mice with a generalized and regulated expres-
sion using the newly identified locus
To finally provide the necessary proof of concept that the
methodology we had developed had indeed delivered novel
integration sites for the ubiquitous and regulated expression
of transgenes we tested locus 19 by generating two novel
reporter mice in which the reporter was driven by differ-
ent promoters to ensure that the expression of the reporter
dependent on the promoter used and not simply associ-
ated with the locus utilized. Thus, we conceived two mice
model: one for the study the activity of the inflammatory
path (NFB-luc2) and the second for the oxidative stress
(ARE-luc2).
As previously stated (6), the ideal ‘path reporter’ should
provide a reliable measure of the process in study in all or-
gans and cells of the organism independently of the sex and
stage of development or age. As a consequence, the expres-
sion of the reporter should be strictly dependent from the
desired stimulus and occurring in all responsive organs at
all stages of development of the animal.
To test the two loci we therefore generated a construct
with: (i) multiple reporter systems to enable in vivo stud-
ies as well as ex vivo analysis of the expression of the re-
porter at the cellular level; (ii) cre-Lox sequences for the se-
lection of the tissues where the transgene is expressed and,
in addition (iii) to further decrease the probabilities of posi-
tion effects we also decided to flank the reporter constructs
with insulator sequences (refer European patent No. EP
1298988B1; US patent No. 7 943 81 (Matrix attachment Re-
gions, MAR).
As reporters we selected a bicistronic system conceived to
contain a gene for in vivo BLI (luc2 gene) and a gene encod-
ing a protein ideal for ex vivo studies at single cell level (td-
Tomato, a monomeric red fluorescent protein derived from
the Discosoma sp. red fluorescent protein) separated by an
IRES.
For the tissue specific expression of the reporter, we used
the cre-loxP system integrating a floxed STOP sequence be-
tween promoter and the bicistronic reporter (29) (Figure
4A). To limit the dimension of the cassette, we tested the
efficiency of different multimers of the original STOP se-
quence (RNA PolII termination signal) proposed by Lasko
et al. (30) and demonstrated by transient transfection, that
a monomer of the STOP sequence was sufficient to com-
pletely block the activity of PolII (Supplementary Figure
S4).
To generate the mouse to study the activation of the in-
flammatory process, we used a promoter cassette developed
in prior experiments that had led us to identify a sequence
regulated by the NFB TF in cells of the innate immunity
selectively; such promoter contained a synthetic stretch of
DNA in which the 4 NFB-binding motifs was repeated
twice (16). Such a promoter was associated with the con-
struct above described (Figure 4A) and used for the gen-
eration of the reporter mouse by homologous recombina-
tion into the line 19 locus. The mice carrying the trans-
gene did not expressed luciferase (Figure 4A) before they
were crossed with the B6.C-Tg(CMV-cre)1Cgn/Jmouse ex-
pressing the Cre recombinase in germ cells (31). Further
demonstration of the tightness of the floxed STOP sequence
was obtained with the quantitative analysis of photon emis-
sion of selected organs dissected from mice prior (NFB-
STOP-luc2) and after the breeding with B6.C-Tg(CMV-
cre)1Cgn/J mice (NFB-luc2). Prior removal of the STOP
sequence the expression of the reporter was in the order of
thousands p/s/cm2/ster, after the removal was at least one
order of magnitude higher (Supplementary Figure S5A). In
both male and female NFB-luc2 mice, the basal expres-
sion of the reporter appeared to be generalized (Figure 4B).
A time-course study with a low dose of pro-inflammatory
molecule LPS showed that the reporter reached the maxi-
mal activity at 3–6 h and was back to the basal level at 24
h after induction (Figure 4C). Most relevant, however, was
the response of the reporter to increasing concentrations of
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Figure 3. Identification of the integration loci of lines 19 and 21. (A and B) Representative images that indicate the intensity of photon emission in organs
explanted from mice of line 19 and 21. The total mice analyzed were 4. Mice were injected with of 80 mg/kg and 3 mg/kg luciferin, respectively, for line 19
and line 21 and tissues were explanted 15 min after the luciferine injection and the exposition time at the CCD was 5 min. (C) Luciferase activity measured
in tissue extracts and expressed as relative luciferase units (RLU) in mice of the lines 19 and 21. The relative luminescence units (RLU) determined during
a measurement of 10 s is expressed as RLU–RLU measured in corresponding wt tissues per microgram protein. Data are expressed as mean ± SEM (n =
4). (D and E) Graphical representation of line 19 (chromosome 1) and line 21 (chromosome 7) loci.
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Figure 4. Regulation of luciferase reporter activity in the NFB-luc2 mouse. (A) Schematic representation of the plasmid vector utilized to generate
NFB-luc2 mouse prior and after excision of STOP sequence. (B) Ventral and dorsal luciferase emission of NFB-luc2 mice (female and male) before
(upper panel) and after (lower panel) breeding with the B6.C-Tg(CMV-cre)1Cgn/J. (C) In vivo BLI: time-course luciferase expression in NFB-luc2 mice
after injection of 1 mg/kg lipopolysaccharide (LPS) (i.p.). BLI is measured ventrally, whole body and expressed as photon emission (p/s/cm2/sr). The
image is representative of 4 individual animals. In the graph, each point corresponds to mean ± SEM (n = 4). (**) P < 0.01 versus 0 h; (***) P < 0.001
versus 0 h. (D) In vivo BLI: dose-response luciferase expression in NFB-luc2 mice after 6 h of i.p. injection of increasing doses of LPS. BLI is expressed
as photon emission (p/s/cm2/sr), and the image is representative of four individual animals. In the graph, each point corresponds to mean ± SEM (n =
4). (**) P < 0.01 versus 0h (***) P < 0.001 versus 0 h. (E) Photon emission measured in 13 organs dissected from NFB-luc2 mice 6 h after i.p. injection
of LPS (1 mg/kg). Each bar corresponds to ratio between BLI measured from four treated mice versus BLI measured from four vehicles. mice (n = 4). (*)
P < 0.05 versus vehicle; (**) P < 0.01 versus vehicle (***); P < 0.001 versus vehicle.
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LPS. The results in Figure 4D showed a strict correlation
between the dose of LPS administered andwhole body BLI.
To better evaluate the ubiquitous expression of the reporter
we carried out an ex vivo analysis on 13 organs explanted 6 h
after 1 mg/kg i.p. injection of LPS. The fact that not all tis-
sues expressed the same amount of luciferase was ascribed
to differences in the presence of cells for the innate immunity
and in the distribution of i.p. injected LPS (e.g. brain) (Fig-
ure 4E). To demonstrate that the activation of the reporter
paralleled that one of target genes, we also compared the ex-
pression of luciferase andwith threeNFB endogenous tar-
get genes. Supplementary Figure S6A shows that Il1β and
Il6 were induced in lung (27-fold and 63-fold, respectively)
and uterus (34-fold and 95-fold, respectively) more than in
adipose tissue (17-fold and 33-fold, respectively), this was
closely reflected by the action of the reporter gene that was
induced in lung (53-fold induction) and uterus (26-fold in-
duction) more than in adipose tissue (15-fold induction)
(Supplementary Figure S6B). Interestingly, another target
of NFB, Cxcl2 was maximally induced in adipose tissue
(390-fold induction) and less induced in uterus (98-fold in-
duction) and lung (32-fold induction) (Supplementary Fig-
ure S6A).
For the generation of the reporter of oxidative stress
we designed the promoter using the same strategy prior
applied to the identification of appropriate ARE for the
Nrf-2 transcription factor. Briefly, we analyzed a panel
of 14 genes known to be involved in the oxidative stress
pathway. Bioinformatic comparative analyses of the se-
quences recognized by the Nrf-2 factor (Supplementary Ta-
ble S1) led us to select a synthetic promoter sequence with
four ARE repeated twice (Figure 5A). Likewise NFB-
luc2, a floxed STOP codon was placed between pro-
moter and bicistronic reporter; therefore, the reporters
were expressed after breeding ARE-STOP-luc2 with B6.C-
Tg(CMV-cre)1Cgn/J mouse (Figure 5B and Supplemen-
tary Figure S5B). Injection of a well-known oxidant, ASN
(12.5 mg/kg i.p. for 6 h) (32), demonstrated that expres-
sion of the reporter was appropriately regulated in the dif-
ferent body areas as indicated by in vivo and ex vivo stud-
ies (Figure 5C–E). The results in Figure 5E were in line
with observations on the toxic effects of ASN where major
effects were observed in urinary tract, respiratory system,
gastro-intestinal apparatus, cardiovascular system, adipose
tissue and renal system (33–35). We also measured Nrf2
mRNA content in different tissues to investigate the ex-
tent to which Nrf2 mRNA abundance reflected the activity
of the reporter. In WT mice Nrf2 resulted more expressed
in lung and adipose tissue than in the uterus: this was in
line with the extent to which the luciferase reporter was
induced (Supplementary Figure S6C and D). ASN treat-
ment affected differently the expression of these two en-
dogenous, target genes: the change in Homox1 mRNA in-
duced by the treatment was very pronounced in muscle (12-
fold), wat (9.5-fold) and lung (8.9-fold); for Nqo1 gene was
in lung (7.5-fold) and uterus (5.9-fold) (Supplementary Fig-
ure S7A). When we studied the effect of the treatment with
ASN on the reporter we measured the highest induction
in wat (15.3-fold), uterus (8.5-fold) and lung (7.6-fold). In
these tissue the activation of the transcription factor was
reported also with the study of the endogenous genes, how-
ever, we did not see activation of BLI in muscle reproducing
what seen with Hmox1, but not Nqo1.
Finally, immunohistochemical analysis demonstrated
that also the second reporter TdTomato was transcribed in
the brain regions known to have a high oxidative potential.
We selected the brain for this study because we wanted to
test the selectivity of the reporter in a complex tissue where
the regions where oxidation is very circumscribed, due to
the high synthesis induced by the presence of dopamine. In
fact Figure 5F shows that the reporter is mainly present in
pars compacta of substantia nigra rich of dopaminergic neu-
rons, while it is very little expressed in the substantia nigra,
pars reticulata poor of dopaminergic neurons. Subsequent
stainingwith anti-Nrf2 antibody showed that this transcrip-
tion factor is highly expressed in the pars compacta but not
in the reticulata (data not shown).
DISCUSSION
We here developed and applied a systematic approach for
the identification of permissive loci for the generation of
‘path reporter mice’ and tested its validity with the valida-
tion of one of the loci identified.
The key feature of such methodology is the use of in vivo
imaging for the identification of the loci enabling the gen-
eralized and regulated expression of the integrated trans-
genes in mice at different developmental stages, age, sex
and trans-generationally. The present study demonstrated
the validity of the methodology set up with the generation
of two novel reporter systems very valuable for the spatio-
temporal study of the activity of two transcription factors
master regulators of the inflammatory (NFB) and the an-
tioxidant and phase II detoxification responses (Nrf2). The
NFB-luc2 reporter mouse was validated to show its spatio-
temporal responsiveness to a strong inflammatory stimulus
(LPS). In the validation procedure, we carried out a com-
parative analysis the extent of expression of luciferase and
three endogenous genes after LPS administration. Each en-
dogenous NFB target showed a tissue-dependent sensitiv-
ity to LPS. This is not surprising because the transcription
of those genes is under the control of complex promoters
controlled by a multiplicity of transcription factors that act
differently spatio-temporally. Thus, considering the expres-
sion of endogenous targets, it is difficult to obtain a con-
clusive indication of the extent of transcriptional activation
of NFB in each tissue. We believe that the use of a min-
imal, synthetic promoter best measures what is the state
of activation of the TF in study because directly propor-
tional to the TF action independently from other signaling
molecules. Thus, this experiment further underlined the use-
fulness of the use of a surrogate reporter of TF activity as
less susceptible than complex promoters to unpredictable
influences able to enhance/suppress the activity of the TF
on that promoter, but not on other targets.
We also developed appropriate vectors for the tissue spe-
cific expression of such transgenes and proved as successful
the use of a shorter, monomeric version of the STOP signal
proposed by Lasko et al. (30).
Thanks to the ever growing selection of fluorescent and
bioluminescent reporter genes available, the identification
of multiple integration sites is the key element for the rapid
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Figure 5. Regulation of luciferase and TdTomato reporter activity in the ARE-luc2mouse. (A) Schematic representation of the plasmid vector and antiox-
idant responsive element (ARE) sequence utilized to generate ARE mouse prior and after excision of STOP sequence. (B) Ventral and dorsal luciferase
emission of ARE-luc2 mice (female and male) before (upper panel) and after (lower panel) breeding with the B6.C-Tg(CMV-cre)1Cgn/J. (C) Activation
of luciferase expression by the administration of ASN. In vivo bioluminescence imaging was done 6 h after i.p. injection of 12.5 mg/kg ASN. The image
is representative of four individuals analyzed. (D) BLI measurement in selected body areas after ASN injection. Each bar corresponds to mean ± SEM
(n = 4), expressed as photon emission (p/s/cm2/sr). (**) P < 0.01 versus vehicle; (***) P < 0.001 versus vehicle. (E) Photon emission measured in 14
organs dissected from ARE-luc2mice 6 h after i.p. injection of ASN (12.5 mg/kg). Each bar corresponds to mean± SEM of tissues obtained four separate
individual mice and BLI is expressed as p/s/cm2/sr. (*) P < 0.05 versus vehicle; (**) P < 0.01 versus vehicle (***); P < 0.001 versus vehicle. (F) BLI and
immunohistochemical analysis of the brain of the mouse reporter for the oxidative stress. Immunohistochemical analysis of brain slices at two magnifi-
cation (20x and 40x): in blue DAPI staining, in red TdTomato protein and merging of the stainings showing cytoplasmic presence of TdTomato. SNpc
substantia nigra pars compacta; SNpr substantia nigra pars reticulata. Images are representative of two animals analyzed separately.
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creation of reliable pluripotent, multiplex reporter systems
facilitating the spatio-temporal analysis of disparate biolog-
ical processes. These novel systems will represent a signif-
icant step forward for our understanding of the molecu-
lar bases of complex and multifactorial pathologies. For in-
stance, interbreeding three reporter systems (e.g. for inflam-
mation, oxidative stress and neuronal death) in a model of
neurodegeneration will clarify the causal relations of neu-
roinflammation and oxidative stress with neuronal death, or
the use of a dual systems expressing reporters for apoptosis
and proliferation will facilitate tremendously the screening
of novel and more specific anti-cancer drugs.
We believe therefore that the methodology set up and the
loci identified will significantly improve the development of
the field.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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